IP Library Granted Patent US 6,921,819
Granted Patent B2
US 6,921,819 · App. 10/332,727 · Granted Jul 26, 2005

Polysaccharide crosslinking, hydrogel preparation, resulting polysaccharide(s) and hydrogel(s), uses thereof

Assignee: Laboratoires d'Esthetique Appliquee
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,921,819
App. No.
10/332,727
Granted
Jul 26, 2005
Kind
B2
Abstract

The invention relates to a process for the crosslinking of polysaccharides. The process of the invention is a process for the crosslinking of at least one polymer selected from polysaccharides and their derivatives, under the action of at least one polyfunctional crosslinking agent, characterized in that said polyfunctional crosslinking agent is reacted with said polymer, in the solid state, during hydration. The invention is applied to the manufacture of hydrogels and gels that can be used, in particular, in plastic or cosmetic surgery.

Claims (65)

1. A process for the crosslinking of at least one polymer selected from hyaluronic acid, its salts and their mixtures, under the action of at least one polyfunctional crosslinking agent, characterized in that said polyfunctional crosslinking agent is reacted with said polymer, in the solid state, during hydration.

2. The crosslinking process according to claim 1 , characterized in that said polyfunctional crosslinking agent reacts with said polymer in basic solution.

3. The cross linking process according to claim 1 , characterized in that said polyfunctional crosslinking agent is an epoxide advantageously selected from 1,4 butanediol diglycidyl ether, 1,2-bis(2,3-epoxypropoxy)ethylene and 1-(2,3-epoxypropyl)-2,3-epoxycyclohexane.

4. The crosslinking process according to claim 3 , characterized in that said polyfunctional crosslinking agent consists of 1,4-butanediol diglycidyl ether.

5. The crosslinking process according to claim 1 , characterized in that said polymer is crosslinked, via its hydroxyl groups, by means of a crosslinking agent to a degree of crosslinking defined by a ratio

R

=

Total

number

of

reactive

groups

in

said

crosslinking

agent

Total

number

of

disaccharide

units

in

the

hyaluronic

acid

molecules

of between 0.10 and 0.50.

6. A process for the preparation of an injectable hydrogel of at least one crosslinked polymer selected from hyaluronic acid, its salts and their mixtures, characterized in that it comprises the crosslinking of said polymer according to claim 1 , followed by the swelling of said crosslinked polymer by hydration.

7. A process for the preparation of an injectable hydrogel of at least one crosslinked polymer selected from hyaluronic acid, its salts and their mixtures, characterized in that it comprises:

a) the crosslinking of said polymer according to claim 1 ;

b) the swelling of said cross linked polymer;

c) the purification of said swollen crosslinked polymer; and

d) the sterilization, if necessary, of said purified swollen crosslinked polymer.

8. The process of claim 1 wherein the said polymer is sodium hyaluronate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2014
From: LABORATOIRES D'ESTHETIQUE APPLIQUEE, SA (LEADERM)
To: CORNEAL INDUSTRIE, SAS
Reel/Frame 032127/0925 →
CHANGE OF NAME Recorded Feb 4, 2014
From: CORNEAL INDUSTRIES, SAS
To: ALLERGAN INDUSTRIE, SAS
Reel/Frame 032157/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2003
From: PIRON, ESTELLE; THOLIN, RAYMONDE
To: LABORATOIRES D'ESTHETIQUE APPLIQUEE
Reel/Frame 014009/0958 →
Priority Claims (1)
FR 00 09497 · Jul 19, 2000 · national
Continuity (1)
Related Publication 20030148995A1 · Aug 7, 2003